Crossref
journal-article
Elsevier BV
Neurobiology of Disease (78)
References
69
Referenced
202
10.1212/01.WNL.0000046523.05125.87
/ Neurology / Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease by Ascherio (2003)10.1038/75556
/ Nat. Genet. / Gene ontology: tool for the unification of biology. The Gene Ontology Consortium by Ashburner (2000)10.1212/WNL.55.9.1358
/ Neurology / Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging by Baldereschi (2000)10.1159/000080707
/ Dev. Neurosci. / A fetal risk factor for Parkinson’s disease by Barlow (2004)10.1523/JNEUROSCI.11-05-01325.1991
/ J. Neurosci. / Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids by Beyer (1991)10.1093/jnen/63.10.1003
/ J. Neuropathol. Exp. Neurol. / DNA chip technology in brain banks: confronting a degrading world by Buesa (2004)10.1097/01.jnen.0000190063.90440.69
/ J. Neuropathol. Exp. Neurol. / Alpha-synuclein and chaperones in dementia with Lewy bodies by Cantuti-Castelvetri (2005)10.1016/j.neurobiolaging.2004.11.008
/ Neurobiol. Aging / Somatic mitochondrial DNA mutations in single neurons and glia by Cantuti-Castelvetri (2005)10.1016/j.brainres.2004.12.009
/ Brain Res. / Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson’s disease by Cass (2005)10.1093/bioinformatics/btg410
/ Bioinformatics / A benchmark for Affymetrix GeneChip expression measures by Cope (2004)10.1097/00001756-200301200-00009
/ NeuroReport / Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle by Datla (2003)10.1016/j.cub.2006.01.017
/ Curr. Biol. / Direct regulation of adult brain function by the male-specific factor SRY by Dewing (2006)10.1016/S0006-8993(00)02329-5
/ Brain Res. / Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats by Disshon (2000)10.1016/0006-8993(95)01566-3
/ Brain Res. / Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice by Dluzen (1996)10.1016/0892-0362(96)00086-4
/ Neurotoxicol. Teratol. / Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice by Dluzen (1996)10.1159/000070278
/ Neuroendocrinology / Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system by Dluzen (2003)10.1002/gepi.1124
/ Genet. Epidemiol. / Empirical Bayes methods and false discovery rates for microarrays by Efron (2002)10.1073/pnas.95.25.14863
/ Proc. Natl Acad Sci. U. S. A. / Cluster analysis and display of genome-wide expression patterns by Eisen (1998)10.1016/S0169-328X(99)00265-X
/ Brain Res. Mol. Brain Res. / Isolation of sex-specific cDNAs from fetal mouse brain using mRNA differential display and representational difference analysis by Eriksson (1999)10.1038/3327
/ Nat. Med. / Real-time quantitative RT-PCR after laser-assisted cell picking by Fink (1998)10.1016/0006-8993(96)00598-7
/ Brain Res. / The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent by Freyaldenhoven (1996)10.1016/j.brainresrev.2004.07.018
/ Brain Res. Brain Res. Rev. / Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease by Fuentealba (2004)10.1016/j.pbb.2004.04.022
/ Pharmacol. Biochem. Behav. / Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson’s disease by Gillies (2004)10.1016/S0896-6273(02)00765-1
/ Neuron / Cadherins communicate structural plasticity of presynaptic and postsynaptic terminals by Goda (2002)10.1007/s00702-004-0212-1
/ J. Neural Transm. / Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes by Grunblatt (2004)10.1002/mds.10173
/ Mov. Disord. / Genetics of parkinsonism by Gwinn-Hardy (2002)- Haaxma, C.A., et al., in press. Gender differences in Parkinson’s disease. J. Neurol., Neurosurg. Psychiatry (2006 Nov. 10, Epub ahead of print).
10.1093/hmg/ddg070
/ Hum. Mol. Genet. / Genomic convergence: identifying candidate genes for Parkinson’s disease by combining serial analysis of gene expression and genetic linkage by Hauser (2003)10.1093/hmg/ddg283
/ Hum. Mol. Genet. / Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies by Iwata (2003)10.1093/brain/124.6.1125
/ Brain / Increased frontal [(18)F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex by Kaasinen (2001)10.1016/S0161-813X(02)00061-X
/ Neurotoxicology / Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson’s disease by Kelada (2002)10.1016/S0006-3223(02)01369-0
/ Biol. Psychiatry / Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects by Laakso (2002)10.1186/1471-2105-6-129
/ BMC Bioinformatics / Considerations when using the significance analysis of microarrays (SAM) algorithm by Larsson (2005)10.1007/s002590000279
/ Eur. J. Nucl. Med. / Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers by Lavalaye (2000)10.1523/JNEUROSCI.20-23-08604.2000
/ J. Neurosci. / Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson’s disease and memory by Leranth (2000)10.1006/meth.2001.1262
/ Methods / Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method by Livak (2001){'key': '10.1016/j.nbd.2007.02.009_bib37', 'first-page': '118', 'article-title': 'Gender differences in Parkinson’s disease', 'volume': '21', 'author': 'Lyons', 'year': '1998', 'journal-title': 'Clin. Neuropharmacol.'}
/ Clin. Neuropharmacol. / Gender differences in Parkinson’s disease by Lyons (1998){'key': '10.1016/j.nbd.2007.02.009_bib38', 'first-page': '356', 'article-title': 'Gene expression profiling of sporadic Parkinson’s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70', 'volume': '1053', 'author': 'Mandel', 'year': '2005', 'journal-title': 'Ann. N. Y. Acad. Sci.'}
/ Ann. N. Y. Acad. Sci. / Gene expression profiling of sporadic Parkinson’s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 by Mandel (2005)10.1086/496902
/ Am. J. Hum. Genet. / High-resolution whole-genome association study of Parkinson disease by Maraganore (2005)10.1007/s100720200082
/ Neurol. Sci. / Parkinson’s disease and reproductive life events by Martignoni (2002)10.1111/j.1749-6632.1998.tb08230.x
/ Ann. N.Y. Acad. Sci. / The impact of gender and estrogen on striatal dopaminergic neurotoxicity by Miller (1998)10.1016/j.nbd.2005.07.010
/ Neurobiol. Dis. / Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson’s disease by Miller (2006)10.1111/j.1365-2990.1994.tb00997.x
/ Neuropathol. Appl. Neurobiol. / Transferrin receptors in the parkinsonian midbrain by Morris (1994)10.1176/appi.ajp.158.9.1492
/ Am. J. Psychiatry / Striatal dopamine transporters and cognitive functioning in healthy men and women by Mozley (2001)10.1002/ana.20064
/ Ann. Neurol. / Pael-R is accumulated in Lewy bodies of Parkinson’s disease by Murakami (2004)10.1016/S0306-4522(02)00578-X
/ Neuroscience / Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females by Murray (2003)10.1016/S1353-8020(02)00052-4
/ Parkinsonism Relat. Disord. / Effect of the neurotoxic dose of methamphetamine on gene expression of parkin and Pael-receptors in rat striatum by Nakahara (2003)10.1016/S0168-0102(98)00010-8
/ Neurosci. Res. / Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid by Nishino (1998)10.1093/hmg/ddg270
/ Hum. Mol. Genet. / Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families by Pankratz (2003)10.1016/S0169-328X(03)00337-1
/ Brain Res. Mol. Brain Res. / Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance by Preece (2003)10.1016/S0169-328X(03)00208-0
/ Brain Res. Mol. Brain Res. / An optimistic view for quantifying mRNA in post-mortem human brain by Preece (2003)10.1038/ng1032
/ Nat. Genet. / Microarray data normalization and transformation by Quackenbush (2002)10.1016/0169-328X(95)00125-C
/ Brain Res. Mol. Brain Res. / Effects of sex and estrogen on tyrosine hydroxylase mRNA in cultured embryonic rat mesencephalon by Raab (1995)10.1212/WNL.62.11.2010
/ Neurology / Risk of Parkinson disease in women: effect of reproductive characteristics by Ragonese (2004)10.1016/0166-2236(91)90047-X
/ Trends Neurosci. / Sexual differentiation of monoaminergic neurons—Genetic or epigenetic? by Reisert (1991)10.1016/j.ygeno.2003.09.017
/ Genomics / Confirming microarray data—Is it really necessary? by Rockett (2004)10.1016/S1353-8020(03)00067-1
/ Parkinsonism Relat. Disord. / Depression in Parkinson’s disease: clinical correlates and outcome by Rojo (2003)10.1007/s10072-004-0364-7
/ Neurol. Sci. / REM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based study by Scaglione (2005)10.1001/jama.286.18.2239
/ JAMA / Complete genomic screen in Parkinson disease: evidence for multiple genes by Scott (2001)10.1002/syn.1084
/ Synapse / Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers by Staley (2001){'key': '10.1016/j.nbd.2007.02.009_bib61', 'series-title': 'Goodman and Gilaman’s The Pharmacological Basis of Therapeutics', 'first-page': '527', 'article-title': 'Treatment of the central nervous system degenerative disorders', 'author': 'Standaert', 'year': '2005'}
/ Goodman and Gilaman’s The Pharmacological Basis of Therapeutics / Treatment of the central nervous system degenerative disorders by Standaert (2005)10.1016/j.bbr.2004.09.002
/ Behav. Brain Res. / Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats by Tamas (2005){'key': '10.1016/j.nbd.2007.02.009_bib63', 'first-page': '133', 'article-title': 'Is the cause of Parkinson’s disease environmental or hereditary? Evidence from twin studies', 'volume': '91', 'author': 'Tanner', 'year': '2003', 'journal-title': 'Adv. Neurol.'}
/ Adv. Neurol. / Is the cause of Parkinson’s disease environmental or hereditary? Evidence from twin studies by Tanner (2003)10.1093/bioinformatics/17.6.520
/ Bioinformatics / Missing value estimation methods for DNA microarrays by Troyanskaya (2001)10.1073/pnas.091062498
/ Proc. Natl. Acad Sci. U. S. A. / Significance analysis of microarrays applied to the ionizing radiation response by Tusher (2001)10.1016/j.parkreldis.2004.10.007
/ Parkinsonism Relat. Disord. / Defining the Parkinson’s disease phenotype: initial symptoms and baseline characteristics in a clinical cohort by Uitti (2005)10.1093/aje/kwg068
/ Am. J. Epidemiol. / Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity by Van Den Eeden (2003)10.1038/sj.npp.1300337
/ Neuropsychopharmacology / Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes by Vawter (2004)10.1016/S0896-6273(03)00143-0
/ Neuron / Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila by Yang (2003)
Dates
Type | When |
---|---|
Created | 18 years, 6 months ago (March 4, 2007, 6:52 a.m.) |
Deposited | 1 year, 6 months ago (Feb. 10, 2024, 1:26 p.m.) |
Indexed | 1 week, 3 days ago (Aug. 27, 2025, 12:22 p.m.) |
Issued | 18 years, 3 months ago (June 1, 2007) |
Published | 18 years, 3 months ago (June 1, 2007) |
Published Print | 18 years, 3 months ago (June 1, 2007) |
@article{Cantuti_Castelvetri_2007, title={Effects of gender on nigral gene expression and parkinson disease}, volume={26}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2007.02.009}, DOI={10.1016/j.nbd.2007.02.009}, number={3}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Cantuti-Castelvetri, Ippolita and Keller-McGandy, Christine and Bouzou, Bérengère and Asteris, Georgios and Clark, Timothy W. and Frosch, Matthew P. and Standaert, David G.}, year={2007}, month=jun, pages={606–614} }